Addario Lung Cancer Medical Institute

The Addario Lung Cancer Medical Institute (ALCMI) strives to make lung cancer a survivable disease by partnering with innovative minds to fund and manage investigator-initiated trials, forwarding research for new therapeutics, diagnostics, and a better understanding of lung cancer. Services offered: Funding investigator-initiated clinical trials, Providing staff and experts to launch and manage trials, Researching new therapeutics and diagnostics, Understanding lung cancer risk factors and resistance mechanisms, Conducting biomarker trials, Maintaining a biospecimen bank